These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16119595)

  • 1. Decreased number of acetylcholine receptors is the mechanism that alters the time course of muscle relaxants in myasthenia gravis: a study in a rat model.
    De Haes A; Proost JH; De Baets MH; Stassen MH; Houwertjes MC; Wierda JM
    Eur J Anaesthesiol; 2005 Aug; 22(8):591-6. PubMed ID: 16119595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic-pharmacodynamic modeling of rocuronium in case of a decreased number of acetylcholine receptors: a study in myasthenic pigs.
    De Haes A; Proost JH; De Baets MH; Stassen MH; Houwertjes MC; Wierda JM
    Anesthesiology; 2003 Jan; 98(1):133-42. PubMed ID: 12502989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An isolated, antegrade, perfused, peroneal nerve anterior tibialis muscle model in the rat: a novel model developed to study the factors governing the time course of action of neuromuscular blocking agents.
    De Haes A; Houwertjes MC; Proost JH; Wierda JM
    Anesthesiology; 2002 Apr; 96(4):963-70. PubMed ID: 11964606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic/pharmacodynamic modeling of rocuronium in myasthenic patients is improved by taking into account the number of unbound acetylcholine receptors.
    De Haes A; Proost JH; Kuks JB; van den Tol DC; Wierda JM
    Anesth Analg; 2002 Sep; 95(3):588-96, table of contents. PubMed ID: 12198043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of fading responses induced by non-depolarising muscle relaxants in the evoked EMG of the gastrocnemius muscle of the cat.
    Suzuki T; Nagai H; Katsumata N; Ogawa S; Suzuki H
    Acta Anaesthesiol Scand; 1999 Jul; 43(6):658-62. PubMed ID: 10408821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to rocuronium of rat diaphragm as compared with limb muscles.
    Huang L; Yang M; Chen L; Li S
    J Surg Res; 2014 Dec; 192(2):471-9. PubMed ID: 25112806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling of twitch fade based on slow interaction of nondepolarizing muscle relaxants with the presynaptic receptors.
    Bhatt SB; Amann A; Nigrovic V
    J Pharmacokinet Pharmacodyn; 2006 Aug; 33(4):461-83. PubMed ID: 16752087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Train-of-four fade and neuromuscular block in rats: a comparison between pancuronium, vecuronium, and rocuronium.
    Itoh H; Shibata K; Nitta S; Kobayashi T
    Can J Anaesth; 2000 Oct; 47(10):950-5. PubMed ID: 11032268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rocuronium vs vecuronium for neuromuscular block during transsternal thymectomy in the patient with myasthenia gravis].
    Cordero Escobar I
    Rev Esp Anestesiol Reanim; 2011 Dec; 58(10):578-82. PubMed ID: 22263401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between rosuvastatin and rocuronium in rat sciatic-gastrocnemius nerve-muscle preparation.
    Panchasara AK; Patel JC; Vadgama VK; Barvaliya MJ; Tripathi CB
    J Anesth; 2014 Oct; 28(5):727-32. PubMed ID: 24557086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presynaptic inhibitory effects of rocuronium and SZ1677 on [3H]acetylcholine release from the mouse hemidiaphragm preparation.
    Takagi S; Adachi YU; Saubermann AJ; Vizi ES
    Neurochem Int; 2002 Jun; 40(7):655-9. PubMed ID: 11900861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to rocuronium and its determinants in patients with myasthenia gravis: A case-control study.
    Fujimoto M; Terasaki S; Nishi M; Yamamoto T
    Eur J Anaesthesiol; 2015 Oct; 32(10):672-80. PubMed ID: 26086278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A non-immunogenic myasthenia gravis model and its application in a study of transsynaptic regulation at the neuromuscular junction.
    Molenaar PC; Oen BS; Plomp JJ; Van Kempen GT; Jennekens FG; Hesselmans LF
    Eur J Pharmacol; 1991 Apr; 196(1):93-101. PubMed ID: 1874282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the interaction of steroidal neuromuscular blocking drugs with cardiac muscarinic receptors.
    Appadu BL; Lambert DG
    Br J Anaesth; 1994 Jan; 72(1):86-8. PubMed ID: 7906535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in sensitivity to rocuronium among orbicularis oris muscles innervated by normal or damaged facial nerves and gastrocnemius muscle innervated by somatic nerve in rats: combined morphological and functional analyses.
    Zhou RY; Xu J; Chi FL; Chen LH; Li ST
    Laryngoscope; 2012 Aug; 122(8):1831-7. PubMed ID: 22522983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac effects of non-depolarizing neuromuscular blocking agents pancuronium,vecuronium, and rocuronium in isolated rat atria.
    Melnikov AL; Malakhov KY; Helgesen KG; Lathrop DA
    Gen Pharmacol; 1999 Oct; 33(4):313-7. PubMed ID: 10523069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of rate of stimulation on force of contraction in a partially paralyzed rat phrenic nerve hemidiaphragm preparation.
    England AJ; Richards KM; Feldman SA
    Anesth Analg; 1997 Apr; 84(4):882-5. PubMed ID: 9085975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroidal muscle relaxants attenuate the contractile and phosphatidylinositol responses of rat trachea.
    Hashimoto S; Shibata O; Tsuda A; Iwanaga S; Makita T; Sumikawa K
    Res Commun Mol Pathol Pharmacol; 1998 Jun; 100(3):255-63. PubMed ID: 9730005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic analysis of rat tibialis anterior muscles at different stages of experimental autoimmune myasthenia gravis.
    Gomez AM; Vanheel A; Losen M; Molenaar PC; De Baets MH; Noben JP; Hellings N; Martinez-Martinez P
    J Neuroimmunol; 2013 Aug; 261(1-2):141-5. PubMed ID: 23791150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potency and onset of action of neuromuscular blocking drugs.
    Wierda JM; van den Broek L; Schiere S; Maestrone E
    Anesth Analg; 1995 Jun; 80(6):1249-50. PubMed ID: 7762863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.